Jessica Sachs
Chief Tech/Sci/R&D Officer chez COGENT BIOSCIENCES, INC.
Fortune : 8 709 $ au 31/03/2024
Profil
Jessica Sachs is currently the Chief Medical Officer at Cogent Biosciences, Inc. She previously worked as an Associate Director at Genzyme Corp.
from 2010 to 2012 and as a Senior Medical Director-Clinical Research at Takeda Pharmaceutical Co., Ltd.
from 2012 to 2017.
Dr. Sachs holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from Duke University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC.
0,00% | 22/02/2024 | 1 296 ( 0,00% ) | 8 709 $ | 31/03/2024 |
Postes actifs de Jessica Sachs
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/06/2019 |
Anciens postes connus de Jessica Sachs
| Sociétés | Poste | Fin |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/04/2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2012 |
Formation de Jessica Sachs
| Washington University in St. Louis | Doctorate Degree |
| Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
